Alexander Cumbo
2017
In 2017, Alexander Cumbo earned a total compensation of $2.3M as Senior Vice President, Chief Commercial Officer at Sarepta Therapeutics, a 29% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $212,800 |
|---|---|
| Option Awards | $1,103,231 |
| Salary | $353,558 |
| Stock Awards | $636,416 |
| Other | $11,779 |
| Total | $2,317,783 |
Cumbo received $1.1M in option awards, accounting for 48% of the total pay in 2017.
Cumbo also received $212.8K in non-equity incentive plan, $353.6K in salary, $636.4K in stock awards and $11.8K in other compensation.
Rankings
In 2017, Alexander Cumbo's compensation ranked 4,803rd out of 14,666 executives tracked by ExecPay. In other words, Cumbo earned more than 67.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,803 out of 14,666 | 67th |
Division Manufacturing | 1,706 out of 5,770 | 70th |
Major group Chemicals And Allied Products | 505 out of 2,074 | 76th |
Industry group Drugs | 389 out of 1,730 | 78th |
Industry Pharmaceutical Preparations | 308 out of 1,329 | 77th |
Source: SEC filing on April 26, 2018.
Cumbo's colleagues
We found six more compensation records of executives who worked with Alexander Cumbo at Sarepta Therapeutics in 2017.
2017
Douglas Ingram
Sarepta Therapeutics
Chief Executive Officer
2017
Edward Kaye
Sarepta Therapeutics
Chief Executive Officer
2017
Guriqbal Basi
Sarepta Therapeutics
Chief Scientific Officer
2017
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2017
David Howton
Sarepta Therapeutics
General Counsel
2017
Catherine Stehman-Breen
Sarepta Therapeutics